Intelligent Bio Solutions INC. (INBS) — SEC Filings

Overview

Intelligent Bio Solutions INC. (INBS) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Apr 20, 2026: Intelligent Bio Solutions Inc. filed an 8-K on April 20, 2026, reporting under Regulation FD and other events. The filing includes various exhibits, primarily graphic files, suggesting a presentation or update was shared.

Sentiment Summary

Across 50 filings, the sentiment breakdown is: 3 bearish, 47 neutral. The dominant filing sentiment for Intelligent Bio Solutions INC. is neutral.

Filing Type Overview

Intelligent Bio Solutions INC. (INBS) has filed 39 8-K, 3 10-Q, 2 DEF 14A, 1 10-K, 2 DEFA14A, 1 10-K/A, 1 SC 13G, 1 SC 13G/A with the SEC between Nov 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (50)

• Intelligent Bio Solutions Files 8-K with Exhibits — 8-K · Apr 20, 2026 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on April 20, 2026, reporting under Regulation FD and other events. The filing includes various exhibits, primarily g
• 8-K Filing — 8-K · Dec 31, 2025
• Intelligent Bio Solutions Faces Delisting Concerns — 8-K · Dec 16, 2025 Risk: high
  Intelligent Bio Solutions Inc. filed an 8-K on December 16, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The company, f
• Intelligent Bio Solutions Inc. Files 8-K — 8-K · Dec 12, 2025 Risk: medium
  Intelligent Bio Solutions Inc. filed an 8-K on December 12, 2025, reporting material modifications to the rights of security holders, amendments to its articles
• 8-K Filing — 8-K · Dec 2, 2025
• Intelligent Bio Solutions Reports Unregistered Equity Sales — 8-K · Nov 28, 2025 Risk: medium
  Intelligent Bio Solutions Inc. filed an 8-K on November 28, 2025, reporting unregistered sales of equity securities on November 25, 2025. The company, formerly
• INBS Revenue Jumps 27% Amidst Mounting Losses, Going Concern Doubts — 10-Q · Nov 12, 2025 Risk: high
  Intelligent Bio Solutions Inc. (INBS) reported a net loss of $2,983,006 for the three months ended September 30, 2025, an increase from a net loss of $2,685,633
• Intelligent Bio Solutions Inc. Files 8-K on Financials — 8-K · Nov 7, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on November 7, 2025, reporting on results of operations and financial condition as of November 4, 2025. The filing i
• Intelligent Bio Solutions Files 8-K — 8-K · Oct 30, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on October 30, 2025, reporting on financial statements and exhibits. The company, formerly known as GBS Inc., is inc
• Intelligent Bio Solutions Files 8-K on Corporate Governance & Voting — 8-K · Oct 21, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on October 21, 2025, reporting events as of October 16, 2025. The filing covers the departure of directors or office
• Intelligent Bio Solutions Files 8-K — 8-K · Sep 26, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on September 26, 2025, reporting under Regulation FD and including financial statements and exhibits. The company, f
• Intelligent Bio Solutions Inc. Files 8-K — 8-K · Sep 25, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on September 25, 2025, reporting events as of September 20, 2025. The filing primarily concerns financial statements
• INBS Seeks Shareholder Approval for Reverse Split, Warrant Issuance — DEF 14A · Sep 19, 2025 Risk: high
  Intelligent Bio Solutions Inc. (INBS) is holding its Annual Meeting on October 16, 2025, to address several critical proposals impacting its capital structure a
• Intelligent Bio Solutions Files 8-K — 8-K · Sep 17, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on September 17, 2025, reporting other events and financial statements. The company, formerly known as GBS Inc., is
• 10-K Filing — 10-K · Aug 15, 2025
• Intelligent Bio Solutions Files 8-K on Financials — 8-K · Aug 15, 2025 Risk: medium
  Intelligent Bio Solutions Inc. filed an 8-K on August 15, 2025, reporting on its Results of Operations and Financial Condition, as well as Financial Statements
• Intelligent Bio Solutions Inc. Files 8-K on Financials — 8-K · Aug 7, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on August 7, 2025, reporting on its results of operations and financial condition. The filing also includes financia
• Intelligent Bio Solutions Files 8-K — 8-K · Aug 6, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on August 6, 2025, reporting on other events and financial statements. The company, formerly known as GBS Inc., is i
• Intelligent Bio Solutions Inc. Files 8-K — 8-K · Jul 28, 2025 Risk: medium
  Intelligent Bio Solutions Inc. announced on July 25, 2025, the entry into a material definitive agreement and unregistered sales of equity securities. The compa
• Intelligent Bio Solutions Inc. Files 8-K — 8-K · Jul 23, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on July 23, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly
• Intelligent Bio Solutions Files 8-K — 8-K · Jul 16, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on July 16, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly
• Intelligent Bio Solutions Inc. Files 8-K — 8-K · Jul 15, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on July 15, 2025, reporting under Regulation FD and including financial statements and exhibits. The company, former
• Intelligent Bio Solutions Inc. Files 8-K with Director & Compensation Updates — 8-K · Jul 3, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on June 30, 2025, reporting changes in its board of directors and executive compensation arrangements. The filing al
• Intelligent Bio Solutions Inc. Files 8-K — 8-K · May 16, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on May 16, 2025, reporting events as of May 15, 2025. The filing is a Regulation FD Disclosure and includes Financia
• Intelligent Bio Solutions Inc. Files Q3 2025 10-Q — 10-Q · May 13, 2025 Risk: medium
  Intelligent Bio Solutions Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as GBS Inc., is involved in surgical
• Intelligent Bio Solutions Files DEFA14A Proxy Materials — DEFA14A · Apr 29, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed a Definitive Additional Materials (DEFA14A) on April 29, 2025. This filing relates to the company's proxy statement, indica
• Intelligent Bio Solutions Inc. Files Proxy Materials — DEFA14A · Apr 28, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed a Definitive Additional Materials (DEFA14A) on April 28, 2025. This filing concerns proxy materials for the company. The co
• Intelligent Bio Solutions Files Definitive Proxy Statement — DEF 14A · Apr 1, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed a Definitive Proxy Statement (DEF 14A) on April 1, 2025. The filing concerns the company's proxy materials, which are typic
• Intelligent Bio Solutions Inc. Files 8-K — 8-K · Mar 26, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on March 26, 2025, reporting under Regulation FD and including financial statements and exhibits. The company, forme
• Intelligent Bio Solutions Files 8-K — 8-K · Mar 25, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on March 25, 2025, reporting on Regulation FD disclosures and financial statements. The company, formerly known as G
• Intelligent Bio Solutions Files 8-K — 8-K · Mar 21, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on March 20, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly
• Intelligent Bio Solutions Files 8-K on Shareholder Nominations — 8-K · Mar 14, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on March 14, 2025, reporting on shareholder nominations pursuant to Exchange Act Rule 14a-11 and other events. The f
• Intelligent Bio Solutions Inc. Files 8-K — 8-K · Mar 12, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on March 12, 2025, reporting on events that occurred on March 11, 2025. The filing is primarily informational, detai
• Intelligent Bio Solutions Inc. Files 8-K — 8-K · Feb 21, 2025 Risk: medium
  Intelligent Bio Solutions Inc. announced on February 19, 2025, that it entered into a material definitive agreement. The company also reported on unregistered s
• Intelligent Bio Solutions Inc. Files 10-K/A Amendment — 10-K/A · Feb 13, 2025 Risk: medium
  Intelligent Bio Solutions Inc. filed an amendment (10-K/A) on February 13, 2025, for its fiscal year ended June 30, 2024. The company, formerly known as GBS Inc
• Intelligent Bio Solutions Files 8-K — 8-K · Feb 10, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on February 10, 2025, reporting on its results of operations and financial condition. The filing also includes infor
• Intelligent Bio Solutions Files 8-K — 8-K · Feb 7, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on February 7, 2025, reporting information under Regulation FD Disclosure and Financial Statements and Exhibits. The
• Intelligent Bio Solutions Files 8-K on Financials — 8-K · Feb 6, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on February 6, 2025, reporting on its Results of Operations and Financial Condition, as well as Financial Statements
• Intelligent Bio Solutions Inc. Files 8-K — 8-K · Jan 31, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on January 31, 2025, reporting on Regulation FD disclosures and financial statements. The company, formerly known as
• Intelligent Bio Solutions Files 8-K — 8-K · Jan 29, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on January 29, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, former
• Intelligent Bio Solutions Files 8-K — 8-K · Jan 28, 2025 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on January 28, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, former
• Intelligent Bio Solutions to Acquire Bio-Gen Ltd. for $1.5M — 8-K · Jan 6, 2025 Risk: medium
  Intelligent Bio Solutions Inc. announced on January 2, 2025, that it has entered into a definitive agreement to acquire all of the outstanding equity interests
• Intelligent Bio Solutions Files 8-K — 8-K · Dec 18, 2024 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on December 18, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, forme
• Intelligent Bio Solutions Files 8-K — 8-K · Dec 3, 2024 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on December 3, 2024, primarily for Regulation FD Disclosure and Financial Statements and Exhibits. The filing does n
• Intelligent Bio Solutions Files 8-K — 8-K · Nov 26, 2024 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on November 26, 2024, reporting on Regulation FD disclosures and financial statements. The company, formerly known a
• Intelligent Bio Solutions Acquires Bio-Genetics for $1.5M — 8-K · Nov 20, 2024 Risk: medium
  Intelligent Bio Solutions Inc. announced on November 19, 2024, that it has entered into a definitive agreement to acquire all of the outstanding equity interest
• SC 13G Filing — SC 13G · Nov 14, 2024
• SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Intelligent Bio Solutions Files 8-K — 8-K · Nov 13, 2024 Risk: low
  Intelligent Bio Solutions Inc. filed an 8-K on November 13, 2024, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain
• Intelligent Bio Solutions Inc. Files Q1 2025 10-Q — 10-Q · Nov 7, 2024 Risk: medium
  Intelligent Bio Solutions Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as GBS Inc., is involved in surgical and med

Related Companies

IBIO

Frequently Asked Questions